Which is better, ARGX or HRMY?

On the Buffett-Fit framework, argenx SE (ARGX) currently grades higher than HRMY — 60/100 (C grade) vs 67/100 (B). That said, "better" depends on which framework you trust — ARGX wins on Benjamin Graham, Philip Fisher, Peter Lynch, and Joel Greenblatt; HRMY wins on Warren Buffett, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy ARGX or HRMY?

This page is an educational comparison, not investment advice. Both ARGX and HRMY are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is ARGX better than HRMY for value investing?

On the Buffett-style value-investing framework, ARGX currently grades higher — 67/100 vs 60/100, a 7-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between ARGX and HRMY on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). ARGX currently scores 60/100 (C grade); HRMY scores 67/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, ARGX or HRMY?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. ARGX and HRMY are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, ARGX or HRMY?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are ARGX and HRMY both Healthcare stocks?

Yes — both argenx SE (ARGX) and Harmony Biosciences Holdings, Inc. (HRMY) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this ARGX vs HRMY comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

argenx SE

Harmony Biosciences Holdings

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

ARGX

argenx SE

Market cap

$49.91B

Sector

Healthcare

HRMY

Harmony Biosciences Holdings

Market cap

$1.75B

Sector

Healthcare

Overall winner

argenx SE ARGX

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	ARGX	HRMY	Winner
Warren Buffett	60C	67B	HRMY
Benjamin Graham	74D	60C	ARGX
Philip Fisher

Side-by-side metrics

Metric	ARGX	HRMY
Market cap	$49.91B	$1.75B
P/E (TTM)	44.1x	11.8x
EV/EBIT	44.4x	6.4x
ROIC (TTM)	11.74%	12.5%
Gross margin	89.0%	76.55%
Net margin	33.42%	16.2%
Revenue CAGR 5y	70.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

ARGX leads on

Market cap$49.91Bvs $1.75B+97%
Debt / Equity0.0xvs 0.2x+95%
Revenue CAGR 5y70.0%vs 29.85%+57%
Net margin33.42%vs 16.2%

More like ARGX

ARGX vs HALO ARGX vs LMAT ARGX vs RMD ARGX vs LLY ARGX vs UTHR ARGX vs HAE

More like HRMY

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.